Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 13, 2024 12:39pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
Yes Angler .. take your conspiratorial dogma and politics over to the same DJT 'cats and dogs' eating platform that you come from and support.
(131)
•••
Angler101
X
View Profile
View Bullboard History
Comment by
Angler101
on Sep 13, 2024 11:47am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
Take MY politics elsewhere, Notable?.....oh, but you're allowed to post left-wing propoganda talking points like this that you posted out of the blue 2 days ago, when nobody had posted anything
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 13, 2024 11:36am
RE:RE:Roche & Tecentriq.
September 13, 2024 - SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 13, 2024 11:33am
RE:RE:Breast cancer treatment: perspectives on the oncolytic virus
Patholgists have recently made recommendations to include TILs in the pathology reports of early-stage TNBC worldwide, as it has the potential to inform clinicians and patients when they discuss
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 13, 2024 11:20am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
Take your politics elsewhere. It has become worn in its conspiratorial dogma.
(131)
•••
Angler101
X
View Profile
View Bullboard History
Comment by
Angler101
on Sep 13, 2024 11:14am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
The Russia-China war games going on right now are merely a warm-up in anticipation of a continuation of the weak and feckless Biden-Harris "administration".....If Kamala Harris is elected
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 13, 2024 11:01am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
Having Phase 3 trials run in China do not equate to trials run in the US due to the lack of equivalent rigor and subsequently have nil opportunities for approval in the US or the EU.
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 13, 2024 10:54am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
Russia-China bi-lateral war games have nothing to do with China's intent to infiltrate and usurp the innovative US biopharma and high technology industries.
(131)
•••
Angler101
X
View Profile
View Bullboard History
Comment by
Angler101
on Sep 13, 2024 10:37am
RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
China and Russia are, for the first time in history, conducting bi-lateral wargames in the Pacific, consisting of over 400 warships and over 120 aircraft.....does that tell you anything, Notable?.....
...more
(131)
•••
Angler101
X
View Profile
View Bullboard History
Comment by
Angler101
on Sep 13, 2024 10:29am
RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
China and Russia are for the first time in history, conducting bi-lateral wargames in the Pacific, consisting of over 400 warships and over 120 aircraft.....does that tell you anything, Notable?....no
...more
(108)
•••
CaseyL
X
View Profile
View Bullboard History
Comment by
CaseyL
on Sep 13, 2024 10:28am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
By the looks, they have six phase 3 trials with a management that did not run the company in the ground. I think our current share price/value is about right. ONCY's management is a huge
...more
(17)
•••
throwaway11
X
View Profile
View Bullboard History
Comment by
throwaway11
on Sep 13, 2024 12:12am
RE:RE:Fireside Chat
What is the deal here? I remember listening to Matt Coffee do an interview with a guy from RBC way back in 2020, early 2021 and it seemed like they were on their way somewhere, but the stock is not
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 12, 2024 7:40pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
And Phase 3 Summit Therapeutics whose Chinese owned and trialed bispecific, Ivonescimab, [an investigational therapy not presently approved by any regulatory authority other than China’s
...more
(91)
•••
venture009
X
View Profile
View Bullboard History
Comment by
venture009
on Sep 12, 2024 7:09pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
With a market cap of 302 million ONC would have a share value of approximately $4 / share.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed